Previously, transcriptome-wide mRNA profiling in melanoma cells demonstrated that BRD9 inhibition upregulated pro-apoptotic genes associated with the p53 pathway and downregulated several extracellular matrix proteins required for tumor growth [41,72,78,79,80,81]. The gene discussed is TP53; the disease is neoplasm.